116 related articles for article (PubMed ID: 10103124)
21. Distinct regulations by septide and the neurokinin-1 tachykinin receptor agonist [pro9]substance P of the N-methyl-D-aspartate-evoked release of dopamine in striosome- and matrix-enriched areas of the rat striatum.
Gauchy C; Desban M; Glowinski J; Kemel ML
Neuroscience; 1996 Aug; 73(4):929-39. PubMed ID: 8809812
[TBL] [Abstract][Full Text] [Related]
22. Local GABAergic regulation of the N-methyl-D-aspartate-evoked release of dopamine is more prominent in striosomes than in matrix of the rat striatum.
Krebs MO; Kemel ML; Gauchy C; Desban M; Glowinski J
Neuroscience; 1993 Nov; 57(2):249-60. PubMed ID: 8115037
[TBL] [Abstract][Full Text] [Related]
23. Distinct presynaptic regulation of dopamine release through NMDA receptors in striosome- and matrix-enriched areas of the rat striatum.
Krebs MO; Trovero F; Desban M; Gauchy C; Glowinski J; Kemel ML
J Neurosci; 1991 May; 11(5):1256-62. PubMed ID: 1851217
[TBL] [Abstract][Full Text] [Related]
24. Role of nitric oxide in NMDA-evoked release of [3H]-dopamine from striatal slices.
Hanbauer I; Wink D; Osawa Y; Edelman GM; Gally JA
Neuroreport; 1992 May; 3(5):409-12. PubMed ID: 1633278
[TBL] [Abstract][Full Text] [Related]
25. Modulation of dendritic release of dopamine by N-methyl-D-aspartate receptors in rat substantia nigra.
Araneda R; Bustos G
J Neurochem; 1989 Mar; 52(3):962-70. PubMed ID: 2563759
[TBL] [Abstract][Full Text] [Related]
26. Modulation of striatal dopamine release by glycine transport inhibitors.
Javitt DC; Hashim A; Sershen H
Neuropsychopharmacology; 2005 Apr; 30(4):649-56. PubMed ID: 15688094
[TBL] [Abstract][Full Text] [Related]
27. Inhibitory effects of amphetamine on potassium-stimulated release of [3H]dopamine from striatal slices and synaptosomes.
Bowyer JF; Masserano JM; Weiner N
J Pharmacol Exp Ther; 1987 Jan; 240(1):177-86. PubMed ID: 3100768
[TBL] [Abstract][Full Text] [Related]
28. Riluzole blocks dopamine release evoked by N-methyl-D-aspartate, kainate, and veratridine in the rat striatum.
Keita H; Lepouse C; Henzel D; Desmonts JM; Mantz J
Anesthesiology; 1997 Nov; 87(5):1164-71. PubMed ID: 9366469
[TBL] [Abstract][Full Text] [Related]
29. Effects of arachidonic acid on dopamine synthesis, spontaneous release, and uptake in striatal synaptosomes from the rat.
L'hirondel M; Chéramy A; Godeheu G; Glowinski J
J Neurochem; 1995 Mar; 64(3):1406-9. PubMed ID: 7861174
[TBL] [Abstract][Full Text] [Related]
30. Group-II metabotropic glutamate receptors negatively modulate NMDA transmission at striatal cholinergic terminals: role of P/Q-type high voltage activated Ca++ channels and endogenous dopamine.
Mela F; Marti M; Fiorentini C; Missale C; Morari M
Mol Cell Neurosci; 2006 Feb; 31(2):284-92. PubMed ID: 16249096
[TBL] [Abstract][Full Text] [Related]
31. Pregnenolone sulfate induces NMDA receptor dependent release of dopamine from synaptic terminals in the striatum.
Whittaker MT; Gibbs TT; Farb DH
J Neurochem; 2008 Oct; 107(2):510-21. PubMed ID: 18710414
[TBL] [Abstract][Full Text] [Related]
32. Progesterone in vitro increases NMDA-evoked [3H] dopamine release from striatal slices in proestrus rats.
Cabrera RJ; Navarro CE
Neuropharmacology; 1996 Feb; 35(2):175-8. PubMed ID: 8734486
[TBL] [Abstract][Full Text] [Related]
33. NMDA regulation of dopamine release from proximal and distal dendrites in the cat substantia nigra.
Gauchy C; Desban M; Glowinski J; Kemel ML
Brain Res; 1994 Jan; 635(1-2):249-56. PubMed ID: 8173961
[TBL] [Abstract][Full Text] [Related]
34. Modulation of the Ca++-evoked release of [3H]dopamine from striatal synaptosomes by dopamine (D2) agonists and antagonists.
Bowyer JF; Weiner N
J Pharmacol Exp Ther; 1987 Apr; 241(1):27-33. PubMed ID: 3572788
[TBL] [Abstract][Full Text] [Related]
35. Lack of autoreceptor-mediated inhibitory control of dopamine release in striatal synaptosomes of D2 receptor-deficient mice.
L'hirondel M; Chéramy A; Godeheu G; Artaud F; Saiardi A; Borrelli E; Glowinski J
Brain Res; 1998 May; 792(2):253-62. PubMed ID: 9593923
[TBL] [Abstract][Full Text] [Related]
36. NMDA receptor activation stimulates phospholipase A2 and somatostatin release from rat cortical neurons in primary cultures.
Tapia-Arancibia L; Rage F; Récasens M; Pin JP
Eur J Pharmacol; 1992 Mar; 225(3):253-62. PubMed ID: 1355446
[TBL] [Abstract][Full Text] [Related]
37. Involvement of cholinergic presynaptic receptors of nicotinic and muscarinic types in the control of the spontaneous release of dopamine from striatal dopaminergic terminals in the rat.
Giorguieff MF; Le Floc'h ML; Glowinski J; Besson MJ
J Pharmacol Exp Ther; 1977 Mar; 200(3):535-44. PubMed ID: 850127
[TBL] [Abstract][Full Text] [Related]
38. NMDA and non-NMDA ionotropic glutamate receptors modulate striatal acetylcholine release via pre- and postsynaptic mechanisms.
Morari M; Sbrenna S; Marti M; Caliari F; Bianchi C; Beani L
J Neurochem; 1998 Nov; 71(5):2006-17. PubMed ID: 9798925
[TBL] [Abstract][Full Text] [Related]
39. In vivo modulation of excitatory amino acid receptors: microdialysis studies on N-methyl-D-aspartate-evoked striatal dopamine release and effects of antagonists.
Carrozza DP; Ferraro TN; Golden GT; Reyes PF; Hare TA
Brain Res; 1992 Mar; 574(1-2):42-8. PubMed ID: 1353403
[TBL] [Abstract][Full Text] [Related]
40. Cholinergic modulation of N-methyl-D-aspartate-evoked [3H]norepinephrine release from rat cortical slices.
Gonzales RA; Roper LC; Westbrook SL
J Pharmacol Exp Ther; 1993 Jan; 264(1):282-8. PubMed ID: 8423531
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
